Yossi Ben Amram
Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
January 04, 2024 08:00 ET | Quris Technologies
Former Biogen CEO Michel Vounatsos Joins Quris-AI Board; Yossi Ben Amram Appointed President as BioAI Innovator Continues to Expand
blue-white.png
Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
September 28, 2023 08:00 ET | Quris Technologies
Merck KGaA and Quris-AI Expand Collaboration After a Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety Platform
blue-white.png
独メルクとクリスAIが協働を拡大
September 28, 2023 08:00 ET | Quris Technologies
ボストンおよびイスラエル・テルアビブ発, Sept. 28, 2023 (GLOBE NEWSWIRE) -- 医薬品分野に革命をもたらしている人工知能 (AI) のイノベーターであるクリスAI (Quris-AI) は本日、大手サイエンス・テクノロジー会社の独メルク (Merck KGaA) (ドイツ・ダルムシュタット) との協働の拡大を発表した。...
blue-white.png
Quris-AI Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
March 02, 2023 07:00 ET | Quris Technologies
BOSTON and TEL-AVIV, Israel, March 02, 2023 (GLOBE NEWSWIRE) -- Quris-AI, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023. This year’s...
blue-white.png
Quris-AI and MBZUAI to launch world-class Bio-AI center in Abu-Dhabi
January 18, 2023 06:14 ET | Quris Technologies
ABU DHABI, United Arab Emirates, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Quris-AI and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) signed an agreement during Abu Dhabi Sustainability...
blue-white.png
Quris Earns Additional Seed Investment Led by SoftBank Vision Fund 2
December 20, 2022 08:00 ET | Quris Technologies
BOSTON and TEL-AVIV, Israel, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has secured an additional $9...
blue-white.png
Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction
February 10, 2022 00:00 ET | Quris Technologies
BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed an agreement with...
blue-white.png
Quris Closes $28 Million in Seed Funding From Top Institutional Investors
January 11, 2022 14:45 ET | Quris Technologies
BOSTON and TEL-AVIV, Israel, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced the final close of $28 million in...
blue-white.png
Quris Closes Critical Drug Development Gaps With New Clinical Prediction AI Platform
October 18, 2021 07:30 ET | Quris Technologies
BOSTON and TEL-AVIV, Israel, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today launched the first clinical prediction AI...
ReportLinker logo.jpg
Microtasking Market Research Report by Task Type, by Customer Type, by Task, by End-users, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
October 14, 2021 07:19 ET | ReportLinker
New York, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Microtasking Market Research Report by Task Type, by Customer Type, by Task, by End-users, by Region...